Achieve Life Sciences Appoints Craig Donnelly as New COO

Achieve Life Sciences, listed on NASDAQ under the ticker symbol ACHV, has announced the promotion of Craig Donnelly to the position of Chief Operating Officer (COO). This strategic move is aimed at enhancing the company’s operational capabilities as it prepares for a significant product launch expected in mid to late 2026.

In his new role, Donnelly will oversee the company’s supply chain and manufacturing operations while aligning these functions with Achieve’s commercial strategy. His extensive experience, which spans more than 25 years in the biopharmaceutical sector, positions him well to guide these critical areas.

Donnelly has a proven track record in the industry, having held various leadership roles where he successfully managed product development and operational efficiency. His expertise will be vital for Achieve Life Sciences as it navigates the complexities of bringing new products to market.

The appointment of Donnelly comes at a pivotal time for Achieve Life Sciences, which is focusing on advancing its pipeline of therapeutics. As COO, he will play a crucial role in ensuring that the company meets its operational targets and delivers on its promise to stakeholders.

With the anticipation of the upcoming product launch, Achieve Life Sciences is poised to strengthen its market position. The leadership change reflects the company’s commitment to operational excellence and strategic growth in the competitive biopharmaceutical landscape.